fda glp-1 warning news november 2025 Compounded" drugs | Health Communication Research Laboratory From a new Perspective by

Consult your healthcare professional before use if you have a medical condition, are taking medication, are using a GLP-1 receptor agonist, or are under medical supervision

FDA-approved & injectable

Metabolic tracing of the isolated intestinal crypts further suggested that fructolysis activity is coupled to the ATP/ADP ratio in the L-cell-resident niche

LLY is expanding its revenue base beyond Mounjaro and Zepbound with new launches and label expansions that can strengthen long-term growth.

People taking GLP-1s had reduced risk for atrial fibrillation, regardless of whether they lost weight or how much they lost, according to findings presented at Heart Rhythm 2026

With a plethora of mixed opinions about whether or not they should be prescribed and a good amount of misinformation about side effects and risks, it can be a highly political and confusing landscape